Publications by authors named "Karen R Rabin"

51Publications

An Mb1-Cre-driven oncogenic Kras mutation results in a mouse model of T-acute lymphoblastic leukemia/lymphoma with short latency and high penetrance.

Leukemia 2020 Sep 11. Epub 2020 Sep 11.

Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine (BCM), Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-01036-wDOI Listing
September 2020

Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia.

Pediatr Blood Cancer 2020 Jun 23:e28525. Epub 2020 Jun 23.

Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28525DOI Listing
June 2020

Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Anticancer Res 2020 Jun;40(6):3147-3153

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.14296DOI Listing
June 2020

Utilization of archived neonatal dried blood spots for genome-wide genotyping.

PLoS One 2020 21;15(2):e0229352. Epub 2020 Feb 21.

Department of Pediatrics, Hematology-Oncology Section, Baylor College of Medicine, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229352PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034898PMC
May 2020

Optimizing Targeted Therapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Authors:
Karen R Rabin

JAMA Oncol 2020 Mar;6(3):333-334

Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.5849DOI Listing
March 2020

Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia.

EBioMedicine 2019 Oct 17;48:49-57. Epub 2019 Oct 17.

Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX, USA; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston TX, USA; Department of Paediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.09.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838385PMC
October 2019

Maternal Residential Proximity to Major Roadways and the Risk of Childhood Acute Leukemia: A Population-Based Case-Control Study in Texas, 1995-2011.

Int J Environ Res Public Health 2019 06 7;16(11). Epub 2019 Jun 7.

Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, One Baylor Plaza, MS: BCM622, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijerph16112029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603856PMC
June 2019

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.

J Clin Oncol 2018 10 23;36(29):2926-2934. Epub 2018 Aug 23.

Stuart S. Winter, Children's Minnesota Cancer and Blood Disorders Program, Minneapolis, MN; Kimberly P. Dunsmore, Carilion Clinic, Roanoke, VA; Meenakshi Devidas and Zhiguo Chen, University of Florida, Gainesville, FL; Brent L. Wood, Seattle Children's Hospital, Seattle, WA; Natia Esiashvili, Emory University, Atlanta, GA; Nancy Eisenberg, University of New Mexico Health Sciences Center, Albuquerque, NM; Nikki Briegel, Princess Margaret Hospital for Children, Perth, Western Australia, Australia; Robert J. Hayashi, St Louis Children's Hospital, St Louis, MO; Julie M. Gastier-Foster, Nationwide Children's Hospital; Julie M. Gastier-Foster and Nyla A. Heerema, Ohio State University, Columbus, OH; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Barbara L. Asselin, University of Rochester Medical Center and Wilmot Cancer Institute, Rochester; Elizabeth A. Raetz and William L. Carroll, Perlmutter Cancer Center at NYU Langone Health, New York, NY; Paul S. Gaynon, Children's Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California, San Francisco, San Francisco, CA; Michael J. Borowitz, Johns Hopkins University, Baltimore, MD; Karen R. Rabin, Baylor College of Medicine, Houston; Naomi J. Winick, University of Texas Southwestern, Dallas, TX; Patrick A. Zweidler-Mckay, ImmunoGen, Waltham, MA; and Stephen P. Hunger, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.7250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366301PMC
October 2018

Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.

J Clin Oncol 2018 05 2;36(13):1330-1338. Epub 2018 Mar 2.

Lia Gore, University of Colorado School of Medicine/Children's Hospital Colorado, Aurora, CO; Pamela R. Kearns, University of Birmingham, Birmingham, West Midlands; Donna Lancaster, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Maria Lucia de Martino Lee, Support Group for Children and Adolescents with Cancer; Carmino Antonio De Souza, University of Campinas, São Paulo, Brazil; Yves Bertrand, L'Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France; Nobuko Hijiya, Ann and Robert H. Lurie Children's Hospital of Chicago, and Northwestern University Feinberg School of Medicine, Chicago, IL; Linda C. Stork, Oregon Health & Science University, Portland, OR; Nack-Gyun Chung, The Catholic University of Korea, Seoul St. Mary's Hospital; Jong Jin Seo, University of Ulsan College of Medicine, and Asan Medical Center, Seoul, Republic of Korea; Rocio Cardenas Cardos, Instituto Nacional De Pediatria, Mexico City, Mexico; Tapan Saikia, Prince Aly Khan Hospital, Mumbai, India; Franca Fagioli, Regina Margherita Hospital, Turin, Italy; Judith Landman-Parker, Hôpital Enfants Armand-Trousseau, Paris, France; Andrew E. Place, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Karen R. Rabin, Texas Children's Cancer Center, and Baylor College of Medicine, Houston, TX; Mariana Sacchi and Rene Swanink, Bristol-Myers Squibb, Princeton, NJ; C. Michel Zwaan, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands; Pamela R. Kearns and C. Michel Zwaan, Innovative Therapies for Children with Cancer Consortium, European Union.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.9597DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929218PMC
May 2018

Self-reported adherence in ALL: true or false?

Authors:
Karen R Rabin

Blood 2017 04;129(14):1888-1889

BAYLOR COLLEGE OF MEDICINE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-02-767525DOI Listing
April 2017

Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia.

Pediatr Blood Cancer 2017 Sep 7;64(9). Epub 2017 Mar 7.

Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26487DOI Listing
September 2017

First do no harm: infectious deaths in pediatric ALL.

Authors:
Karen R Rabin

Blood 2014 Aug;124(7):987-9

BAYLOR COLLEGE OF MEDICINE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-06-581603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133499PMC
August 2014

G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol.

Leuk Res 2014 Feb 14;38(2):210-7. Epub 2013 Oct 14.

Department of Pathology & Immunology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.10.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946941PMC
February 2014

Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy.

Clin Cancer Res 2013 Sep 9;19(18):5079-91. Epub 2013 Jul 9.

Authors' Affiliations: Center for Cell and Gene Therapy, Departments of Pediatrics, Medicine, and Immunology, Baylor College of Medicine; The Methodist Hospital; Texas Children's Hospital; Texas Children's Cancer Center, Houston, Texas; and Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778051PMC
September 2013

The adolescent and young adult with cancer: state of the art-- acute leukemias.

Curr Oncol Rep 2013 Aug;15(4):317-24

Department of Pediatric Hematology/Oncology, Baylor College of Medicine, Texas Children's Cancer Center, 1102 Bates St., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0325-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758222PMC
August 2013

Attacking remaining challenges in childhood leukemia.

Authors:
Karen R Rabin

N Engl J Med 2012 Apr;366(15):1445-6

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMe1200989
Publisher Site
http://dx.doi.org/10.1056/NEJMe1200989DOI Listing
April 2012

Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.

Pediatr Blood Cancer 2012 Apr 21;58(4):633-5. Epub 2011 Nov 21.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279631PMC
April 2012

Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.

Pediatr Blood Cancer 2012 Sep 18;59(3):468-74. Epub 2011 Nov 18.

Division of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23395DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290726PMC
September 2012

Management strategies in acute lymphoblastic leukemia.

Oncology (Williston Park) 2011 Apr;25(4):328-35

Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, 77030, USA.

View Article

Download full-text PDF

Source
April 2011

Malignancy in children with trisomy 21.

Oncologist 2009 Feb 28;14(2):164-73. Epub 2009 Jan 28.

Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761094PMC
February 2009

Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.

Br J Haematol 2009 Mar 20;144(6):930-2. Epub 2008 Dec 20.

Division of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07552.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724897PMC
March 2009

Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia.

Leuk Res 2009 Feb 20;33(2):336-9. Epub 2008 Aug 20.

Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.07.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637345PMC
February 2009

Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.

Expert Rev Cardiovasc Ther 2005 May;3(3):465-71

The C Sheba Medical Center, Tel Hashomer, 52621, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14779072.3.3.465DOI Listing
May 2005